Company · CIK 1129928
ONCOLYTICS BIOTECH INC
| CIK | 1129928 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | NV |
| Business address | CA |
| Listed | ONCY (Nasdaq) |
| First annual or quarterly report | 2002-06-14 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-294811 | 2026-04-01 | 2026-04-06 | 3 | |
| 333-289819 | 2025-08-22 | 2026-04-01 | 4 |
Filings
15| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-04-06 | 424B5Shelf takedown | 333-294811 | 0001104659-26-039932 |
| 2026-04-03 | EFFECTDeclared effective | 333-294811 | 9999999995-26-001090 |
| 2026-04-01 | EFFECTDeclared effective | 333-289819 | 9999999995-26-001039 |
| 2026-04-01 | S-3Shelf registered | 333-294811 | 0001104659-26-038078 |
| 2025-12-09 | EFFECTDeclared effective | 333-290954 | 9999999995-25-003608 |
| 2025-10-17 | 424B5Shelf takedown | 333-289819 | 0001104659-25-100414 |
| 2025-08-29 | EFFECTDeclared effective | 333-289819 | 9999999995-25-002795 |
| 2025-08-22 | F-3Shelf registered | 333-289819 | 0001104659-25-081954 |
| 2024-08-01 | EFFECTDeclared effective | 333-281009 | 9999999995-24-002364 |
| 2022-06-17 | EFFECTDeclared effective | 333-265510 | 9999999995-22-001819 |
| 2020-06-15 | EFFECTDeclared effective | 333-239025 | 9999999995-20-001434 |
| 2018-05-07 | EFFECTDeclared effective | 333-224432 | 9999999995-18-001161 |
| 2014-08-04 | EFFECTDeclared effective | 333-197633 | 9999999995-14-002382 |
| 2012-07-09 | EFFECTDeclared effective | 333-182260 | 9999999995-12-002109 |
| 2008-06-24 | EFFECTDeclared effective | 333-151513 | 9999999995-08-002007 |